Labetalol hydrochloride - Drug Shortage Information

Public shortage context is available across 14 visible exact NDC pages for this generic family.

This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.

Family summary

Current and historical shortage references are available across related Labetalol hydrochloride presentations from multiple manufacturers.

7 current shortage context pages.
7 historical shortage context pages.
6 manufacturers represented.

Related research paths

Labetalol hydrochloride catalog familyBrowse all visible Labetalol hydrochloride presentations in the broader catalog.Hikma Pharmaceuticals USA Inc.4 shortage-bearing exact NDC pages.Hospira, Inc.3 shortage-bearing exact NDC pages.Baxter Healthcare Corporation2 shortage-bearing exact NDC pages.

Common brands and presentations in this family

These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.

labetalol hydrochloride 5 mg / mL Injection 20 mL - NDC 25021-0317-20Sagent Pharmaceuticals | 1 Vial labetalol hydrochloride 5 mg / mL Injection 40 mL - NDC 25021-0317-40Sagent Pharmaceuticals | 1 Vial Labetalol Hydrochloride 5 mg / mL Injection 4 mL - NDC 36000-0320-10Baxter Healthcare Corporation | 10 Vial Labetalol Hydrochloride 5 mg / mL Injection 20 mL - NDC 00143-9622-01Hikma Pharmaceuticals USA Inc. | 1 Vial Labetalol Hydrochloride 5 mg / mL Injection 20 mL - NDC 00409-0125-25Hospira, Inc. | 25 Vial, Multi-Dose

Exact NDC product pages in this shortage family

Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.

Drug Name	NDC 11	Manufacturer	Shortage Context
labetalol hydrochloride 5 mg / mL Injection 20 mL NDC 25021-0317-20 \| 1 Vial \| Sagent Pharmaceuticals	25021-0317-20	Sagent Pharmaceuticals	Current shortage context
labetalol hydrochloride 5 mg / mL Injection 40 mL NDC 25021-0317-40 \| 1 Vial \| Sagent Pharmaceuticals	25021-0317-40	Sagent Pharmaceuticals	Current shortage context
Labetalol Hydrochloride 5 mg / mL Injection 4 mL NDC 36000-0320-10 \| 10 Vial \| Baxter Healthcare Corporation	36000-0320-10	Baxter Healthcare Corporation	Current shortage context
Labetalol Hydrochloride 5 mg / mL Injection 20 mL NDC 00143-9622-01 \| 1 Vial \| Hikma Pharmaceuticals USA Inc.	00143-9622-01	Hikma Pharmaceuticals USA Inc.	Current shortage context
Labetalol Hydrochloride 5 mg / mL Injection 20 mL NDC 00409-0125-25 \| 25 Vial, Multi-Dose \| Hospira, Inc.	00409-0125-25	Hospira, Inc.	Current shortage context
Labetalol Hydrochloride 5 mg / mL Injection 40 mL NDC 00409-2267-54 \| 1 Vial, Multi-Dose \| Hospira, Inc.	00409-2267-54	Hospira, Inc.	Current shortage context
Labetalol Hydrochloride 5 mg / mL Injection 4 mL NDC 00409-2339-34 \| 10 Carton \| Hospira, Inc.	00409-2339-34	Hospira, Inc.	Current shortage context
Labetalol Hydrochloride 5 mg / mL Injection 20 mL NDC 36000-0322-02 \| 1 Vial \| Baxter Healthcare Corporation	36000-0322-02	Baxter Healthcare Corporation	Historical shortage context
Labetalol Hydrochloride 5 mg / mL Injection 20 mL NDC 72266-0102-01 \| 1 Vial, Multi-Dose \| Fosun Pharma USA Inc.	72266-0102-01	Fosun Pharma USA Inc.	Historical shortage context
Labetalol Hydrochloride 5 mg / mL Injection 40 mL NDC 72266-0103-01 \| 1 Vial, Multi-Dose \| Fosun Pharma USA Inc.	72266-0103-01	Fosun Pharma USA Inc.	Historical shortage context
Labetalol Hydrochloride 5 mg / mL Injection 4 mL NDC 00143-9183-10 \| 10 Vial \| Hikma Pharmaceuticals USA Inc.	00143-9183-10	Hikma Pharmaceuticals USA Inc.	Historical shortage context
Labetalol Hydrochloride 5 mg / mL Injection 20 mL NDC 00143-9320-01 \| 1 Vial \| Hikma Pharmaceuticals USA Inc.	00143-9320-01	Hikma Pharmaceuticals USA Inc.	Historical shortage context
Labetalol Hydrochloride 5 mg / mL Injection 40 mL NDC 00143-9623-01 \| 1 Vial \| Hikma Pharmaceuticals USA Inc.	00143-9623-01	Hikma Pharmaceuticals USA Inc.	Historical shortage context
Labetalol Hydrochloride 200 mg / 1 Tablet 100 Tablet, Film Coated (Labetalol HCL) NDC 49884-0123-01 \| 100 Tablet, Film Coated \| Par Health USA, LLC	49884-0123-01	Par Health USA, LLC	Historical shortage context

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.